nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—ALB—acquired immunodeficiency syndrome	0.218	1	CbGaD
Liotrix—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0427	0.0775	CbGbCtD
Liotrix—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0415	0.0753	CbGbCtD
Liotrix—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0403	0.0732	CbGbCtD
Liotrix—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.0391	0.071	CbGbCtD
Liotrix—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0375	0.0681	CbGbCtD
Liotrix—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0375	0.0681	CbGbCtD
Liotrix—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0354	0.0642	CbGbCtD
Liotrix—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0354	0.0642	CbGbCtD
Liotrix—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.0313	0.0568	CbGbCtD
Liotrix—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0198	0.0359	CbGbCtD
Liotrix—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0198	0.0359	CbGbCtD
Liotrix—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0194	0.0352	CbGbCtD
Liotrix—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0186	0.0337	CbGbCtD
Liotrix—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.015	0.0272	CbGbCtD
Liotrix—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.015	0.0272	CbGbCtD
Liotrix—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0148	0.0268	CbGbCtD
Liotrix—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0144	0.0261	CbGbCtD
Liotrix—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0134	0.0243	CbGbCtD
Liotrix—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0115	0.021	CbGbCtD
Liotrix—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0112	0.0203	CbGbCtD
Liotrix—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0101	0.0184	CbGbCtD
Liotrix—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0101	0.0184	CbGbCtD
Liotrix—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00972	0.0176	CbGbCtD
Liotrix—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00752	0.0136	CbGbCtD
Liotrix—SERPINA7—blood plasma—acquired immunodeficiency syndrome	0.0041	0.0666	CbGeAlD
Liotrix—TTR—blood plasma—acquired immunodeficiency syndrome	0.00188	0.0306	CbGeAlD
Liotrix—SERPINA7—blood—acquired immunodeficiency syndrome	0.0015	0.0244	CbGeAlD
Liotrix—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.00148	0.0241	CbGeAlD
Liotrix—SERPINA7—bone marrow—acquired immunodeficiency syndrome	0.00145	0.0236	CbGeAlD
Liotrix—SERPINA7—spinal cord—acquired immunodeficiency syndrome	0.00145	0.0235	CbGeAlD
Liotrix—SERPINA7—nervous system—acquired immunodeficiency syndrome	0.00122	0.0198	CbGeAlD
Liotrix—SERPINA7—central nervous system—acquired immunodeficiency syndrome	0.00117	0.0191	CbGeAlD
Liotrix—TTR—retina—acquired immunodeficiency syndrome	0.00103	0.0168	CbGeAlD
Liotrix—SLCO4C1—blood—acquired immunodeficiency syndrome	0.000967	0.0157	CbGeAlD
Liotrix—SLCO4C1—bone marrow—acquired immunodeficiency syndrome	0.000936	0.0152	CbGeAlD
Liotrix—SLCO4A1—retina—acquired immunodeficiency syndrome	0.000923	0.015	CbGeAlD
Liotrix—SLCO4C1—vagina—acquired immunodeficiency syndrome	0.000896	0.0146	CbGeAlD
Liotrix—THRA—spinal cord—acquired immunodeficiency syndrome	0.000893	0.0145	CbGeAlD
Liotrix—SLCO1B3—vagina—acquired immunodeficiency syndrome	0.000871	0.0142	CbGeAlD
Liotrix—SLC10A1—digestive system—acquired immunodeficiency syndrome	0.00086	0.014	CbGeAlD
Liotrix—THRB—vagina—acquired immunodeficiency syndrome	0.000859	0.014	CbGeAlD
Liotrix—TTR—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.00085	0.0988	CbGpPWpGaD
Liotrix—SLCO4C1—lung—acquired immunodeficiency syndrome	0.000848	0.0138	CbGeAlD
Liotrix—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000844	0.0137	CbGeAlD
Liotrix—SLCO1B3—lung—acquired immunodeficiency syndrome	0.000824	0.0134	CbGeAlD
Liotrix—THRB—lung—acquired immunodeficiency syndrome	0.000813	0.0132	CbGeAlD
Liotrix—THRA—lung—acquired immunodeficiency syndrome	0.000813	0.0132	CbGeAlD
Liotrix—SLC16A2—spinal cord—acquired immunodeficiency syndrome	0.000809	0.0132	CbGeAlD
Liotrix—SLC16A2—vagina—acquired immunodeficiency syndrome	0.000779	0.0127	CbGeAlD
Liotrix—THRA—nervous system—acquired immunodeficiency syndrome	0.000753	0.0122	CbGeAlD
Liotrix—THRB—nervous system—acquired immunodeficiency syndrome	0.000753	0.0122	CbGeAlD
Liotrix—SLCO1C1—spinal cord—acquired immunodeficiency syndrome	0.000743	0.0121	CbGeAlD
Liotrix—SLC16A2—lung—acquired immunodeficiency syndrome	0.000736	0.012	CbGeAlD
Liotrix—TTR—lymphoid tissue—acquired immunodeficiency syndrome	0.000732	0.0119	CbGeAlD
Liotrix—THRB—central nervous system—acquired immunodeficiency syndrome	0.000725	0.0118	CbGeAlD
Liotrix—THRA—central nervous system—acquired immunodeficiency syndrome	0.000725	0.0118	CbGeAlD
Liotrix—TTR—digestive system—acquired immunodeficiency syndrome	0.000723	0.0118	CbGeAlD
Liotrix—TTR—blood—acquired immunodeficiency syndrome	0.000689	0.0112	CbGeAlD
Liotrix—SLC16A2—nervous system—acquired immunodeficiency syndrome	0.000682	0.0111	CbGeAlD
Liotrix—TTR—bone marrow—acquired immunodeficiency syndrome	0.000667	0.0108	CbGeAlD
Liotrix—Levothyroxine—ALB—acquired immunodeficiency syndrome	0.000666	0.584	CrCbGaD
Liotrix—SLC10A1—nervous system—acquired immunodeficiency syndrome	0.000665	0.0108	CbGeAlD
Liotrix—TTR—spinal cord—acquired immunodeficiency syndrome	0.000664	0.0108	CbGeAlD
Liotrix—SLC16A2—central nervous system—acquired immunodeficiency syndrome	0.000656	0.0107	CbGeAlD
Liotrix—SLCO4A1—digestive system—acquired immunodeficiency syndrome	0.000648	0.0105	CbGeAlD
Liotrix—SLC10A1—central nervous system—acquired immunodeficiency syndrome	0.000641	0.0104	CbGeAlD
Liotrix—SLCO1C1—nervous system—acquired immunodeficiency syndrome	0.000626	0.0102	CbGeAlD
Liotrix—TTR—lung—acquired immunodeficiency syndrome	0.000604	0.00982	CbGeAlD
Liotrix—SLCO1C1—central nervous system—acquired immunodeficiency syndrome	0.000602	0.0098	CbGeAlD
Liotrix—SLCO4A1—spinal cord—acquired immunodeficiency syndrome	0.000595	0.00968	CbGeAlD
Liotrix—SLCO4A1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000586	0.0681	CbGpPWpGaD
Liotrix—SLCO4C1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000586	0.0681	CbGpPWpGaD
Liotrix—SLC16A10—lymphoid tissue—acquired immunodeficiency syndrome	0.000576	0.00936	CbGeAlD
Liotrix—THRB—brain—acquired immunodeficiency syndrome	0.000575	0.00936	CbGeAlD
Liotrix—THRA—brain—acquired immunodeficiency syndrome	0.000575	0.00936	CbGeAlD
Liotrix—SLCO4A1—vagina—acquired immunodeficiency syndrome	0.000573	0.00931	CbGeAlD
Liotrix—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.00057	0.00928	CbGeAlD
Liotrix—TTR—nervous system—acquired immunodeficiency syndrome	0.000559	0.0091	CbGeAlD
Liotrix—THRA—lymph node—acquired immunodeficiency syndrome	0.000556	0.00904	CbGeAlD
Liotrix—THRB—lymph node—acquired immunodeficiency syndrome	0.000556	0.00904	CbGeAlD
Liotrix—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000543	0.00884	CbGeAlD
Liotrix—SLC16A10—blood—acquired immunodeficiency syndrome	0.000542	0.00881	CbGeAlD
Liotrix—SLCO4A1—lung—acquired immunodeficiency syndrome	0.000541	0.00881	CbGeAlD
Liotrix—TTR—central nervous system—acquired immunodeficiency syndrome	0.000539	0.00876	CbGeAlD
Liotrix—SLC16A2—brain—acquired immunodeficiency syndrome	0.000521	0.00848	CbGeAlD
Liotrix—SLC10A1—brain—acquired immunodeficiency syndrome	0.000509	0.00827	CbGeAlD
Liotrix—SLC16A2—lymph node—acquired immunodeficiency syndrome	0.000504	0.00819	CbGeAlD
Liotrix—SLC16A10—vagina—acquired immunodeficiency syndrome	0.000502	0.00817	CbGeAlD
Liotrix—SLCO4A1—nervous system—acquired immunodeficiency syndrome	0.000501	0.00816	CbGeAlD
Liotrix—SLCO1C1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000491	0.0571	CbGpPWpGaD
Liotrix—SLCO4A1—central nervous system—acquired immunodeficiency syndrome	0.000483	0.00785	CbGeAlD
Liotrix—SLCO1C1—brain—acquired immunodeficiency syndrome	0.000478	0.00778	CbGeAlD
Liotrix—SLC16A10—lung—acquired immunodeficiency syndrome	0.000475	0.00772	CbGeAlD
Liotrix—Liothyronine—ALB—acquired immunodeficiency syndrome	0.000474	0.416	CrCbGaD
Liotrix—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000464	0.00755	CbGeAlD
Liotrix—SLCO1C1—lymph node—acquired immunodeficiency syndrome	0.000462	0.00752	CbGeAlD
Liotrix—TTR—brain—acquired immunodeficiency syndrome	0.000428	0.00695	CbGeAlD
Liotrix—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000426	0.00693	CbGeAlD
Liotrix—SLC22A8—blood—acquired immunodeficiency syndrome	0.000422	0.00687	CbGeAlD
Liotrix—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000404	0.00658	CbGeAlD
Liotrix—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000388	0.00631	CbGeAlD
Liotrix—SLCO4A1—brain—acquired immunodeficiency syndrome	0.000383	0.00623	CbGeAlD
Liotrix—SLCO4A1—lymph node—acquired immunodeficiency syndrome	0.00037	0.00602	CbGeAlD
Liotrix—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000359	0.00584	CbGeAlD
Liotrix—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000346	0.00562	CbGeAlD
Liotrix—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000343	0.00558	CbGeAlD
Liotrix—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.00033	0.00537	CbGeAlD
Liotrix—SLC10A1—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000329	0.0383	CbGpPWpGaD
Liotrix—SLC16A10—lymph node—acquired immunodeficiency syndrome	0.000325	0.00528	CbGeAlD
Liotrix—CYP2C8—blood—acquired immunodeficiency syndrome	0.000309	0.00503	CbGeAlD
Liotrix—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000286	0.00466	CbGeAlD
Liotrix—SLCO1B3—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000278	0.0323	CbGpPWpGaD
Liotrix—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000274	0.00446	CbGeAlD
Liotrix—ALB—brain—acquired immunodeficiency syndrome	0.000273	0.00444	CbGeAlD
Liotrix—ALB—lymph node—acquired immunodeficiency syndrome	0.000264	0.00429	CbGeAlD
Liotrix—SLC22A8—brain—acquired immunodeficiency syndrome	0.000262	0.00426	CbGeAlD
Liotrix—ABCB1—retina—acquired immunodeficiency syndrome	0.000221	0.0036	CbGeAlD
Liotrix—SLCO1A2—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000219	0.0254	CbGpPWpGaD
Liotrix—SLCO4C1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000217	0.0253	CbGpPWpGaD
Liotrix—SLCO4A1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000217	0.0253	CbGpPWpGaD
Liotrix—SLCO1B3—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000206	0.024	CbGpPWpGaD
Liotrix—ALB—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.000202	0.0235	CbGpPWpGaD
Liotrix—CYP2C8—brain—acquired immunodeficiency syndrome	0.000192	0.00312	CbGeAlD
Liotrix—THRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—acquired immunodeficiency syndrome	0.000187	0.0218	CbGpPWpGaD
Liotrix—THRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—acquired immunodeficiency syndrome	0.000187	0.0218	CbGpPWpGaD
Liotrix—SLCO1B1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000187	0.0217	CbGpPWpGaD
Liotrix—SLCO1C1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000182	0.0212	CbGpPWpGaD
Liotrix—SLC10A1—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000172	0.02	CbGpPWpGaD
Liotrix—SLCO1A2—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000162	0.0188	CbGpPWpGaD
Liotrix—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.00101	CcSEcCtD
Liotrix—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.00101	CcSEcCtD
Liotrix—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.00101	CcSEcCtD
Liotrix—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000161	0.00101	CcSEcCtD
Liotrix—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000161	0.00101	CcSEcCtD
Liotrix—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.00101	CcSEcCtD
Liotrix—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00016	0.001	CcSEcCtD
Liotrix—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.001	CcSEcCtD
Liotrix—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.001	CcSEcCtD
Liotrix—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.001	CcSEcCtD
Liotrix—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00016	0.001	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000999	CcSEcCtD
Liotrix—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000159	0.000994	CcSEcCtD
Liotrix—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000159	0.000994	CcSEcCtD
Liotrix—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000994	CcSEcCtD
Liotrix—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000993	CcSEcCtD
Liotrix—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000992	CcSEcCtD
Liotrix—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.000992	CcSEcCtD
Liotrix—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.000988	CcSEcCtD
Liotrix—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000988	CcSEcCtD
Liotrix—Rash—Didanosine—acquired immunodeficiency syndrome	0.000158	0.000986	CcSEcCtD
Liotrix—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000985	CcSEcCtD
Liotrix—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000158	0.000985	CcSEcCtD
Liotrix—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000158	0.000985	CcSEcCtD
Liotrix—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000158	0.000985	CcSEcCtD
Liotrix—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000157	0.00256	CbGeAlD
Liotrix—Headache—Didanosine—acquired immunodeficiency syndrome	0.000157	0.000979	CcSEcCtD
Liotrix—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000156	0.000978	CcSEcCtD
Liotrix—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000156	0.000977	CcSEcCtD
Liotrix—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000976	CcSEcCtD
Liotrix—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000156	0.000974	CcSEcCtD
Liotrix—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000974	CcSEcCtD
Liotrix—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000156	0.00253	CbGeAlD
Liotrix—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000155	0.000972	CcSEcCtD
Liotrix—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.00097	CcSEcCtD
Liotrix—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.00097	CcSEcCtD
Liotrix—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.000968	CcSEcCtD
Liotrix—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000967	CcSEcCtD
Liotrix—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.000965	CcSEcCtD
Liotrix—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000154	0.000963	CcSEcCtD
Liotrix—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000154	0.000962	CcSEcCtD
Liotrix—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000154	0.00096	CcSEcCtD
Liotrix—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000153	0.000959	CcSEcCtD
Liotrix—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000959	CcSEcCtD
Liotrix—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000957	CcSEcCtD
Liotrix—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000957	CcSEcCtD
Liotrix—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000954	CcSEcCtD
Liotrix—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000953	CcSEcCtD
Liotrix—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000951	CcSEcCtD
Liotrix—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000151	0.000946	CcSEcCtD
Liotrix—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000946	CcSEcCtD
Liotrix—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000945	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000944	CcSEcCtD
Liotrix—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000943	CcSEcCtD
Liotrix—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000938	CcSEcCtD
Liotrix—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000937	CcSEcCtD
Liotrix—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.000937	CcSEcCtD
Liotrix—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000937	CcSEcCtD
Liotrix—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000934	CcSEcCtD
Liotrix—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.000932	CcSEcCtD
Liotrix—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.000932	CcSEcCtD
Liotrix—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000149	0.000931	CcSEcCtD
Liotrix—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000931	CcSEcCtD
Liotrix—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000149	0.000929	CcSEcCtD
Liotrix—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000149	0.000929	CcSEcCtD
Liotrix—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.000927	CcSEcCtD
Liotrix—TTR—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	0.000148	0.0172	CbGpPWpGaD
Liotrix—ABCB1—blood—acquired immunodeficiency syndrome	0.000148	0.00241	CbGeAlD
Liotrix—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000925	CcSEcCtD
Liotrix—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000925	CcSEcCtD
Liotrix—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000924	CcSEcCtD
Liotrix—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000921	CcSEcCtD
Liotrix—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000921	CcSEcCtD
Liotrix—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000918	CcSEcCtD
Liotrix—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000917	CcSEcCtD
Liotrix—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000146	0.000915	CcSEcCtD
Liotrix—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000907	CcSEcCtD
Liotrix—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000145	0.000904	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000904	CcSEcCtD
Liotrix—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000902	CcSEcCtD
Liotrix—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000901	CcSEcCtD
Liotrix—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000144	0.0009	CcSEcCtD
Liotrix—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000144	0.000897	CcSEcCtD
Liotrix—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000897	CcSEcCtD
Liotrix—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000897	CcSEcCtD
Liotrix—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000143	0.00233	CbGeAlD
Liotrix—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000895	CcSEcCtD
Liotrix—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000894	CcSEcCtD
Liotrix—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.000894	CcSEcCtD
Liotrix—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000894	CcSEcCtD
Liotrix—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000143	0.00232	CbGeAlD
Liotrix—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000891	CcSEcCtD
Liotrix—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.00089	CcSEcCtD
Liotrix—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000887	CcSEcCtD
Liotrix—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000886	CcSEcCtD
Liotrix—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.000886	CcSEcCtD
Liotrix—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.000885	CcSEcCtD
Liotrix—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000884	CcSEcCtD
Liotrix—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000141	0.000884	CcSEcCtD
Liotrix—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000883	CcSEcCtD
Liotrix—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000141	0.000881	CcSEcCtD
Liotrix—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000878	CcSEcCtD
Liotrix—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000878	CcSEcCtD
Liotrix—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000877	CcSEcCtD
Liotrix—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000875	CcSEcCtD
Liotrix—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000874	CcSEcCtD
Liotrix—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000871	CcSEcCtD
Liotrix—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000868	CcSEcCtD
Liotrix—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000867	CcSEcCtD
Liotrix—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000867	CcSEcCtD
Liotrix—SLCO1B1—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000139	0.0161	CbGpPWpGaD
Liotrix—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000866	CcSEcCtD
Liotrix—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000138	0.000863	CcSEcCtD
Liotrix—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000862	CcSEcCtD
Liotrix—ABCB1—vagina—acquired immunodeficiency syndrome	0.000137	0.00223	CbGeAlD
Liotrix—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000858	CcSEcCtD
Liotrix—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000858	CcSEcCtD
Liotrix—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000857	CcSEcCtD
Liotrix—Rash—Stavudine—acquired immunodeficiency syndrome	0.000137	0.000856	CcSEcCtD
Liotrix—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000855	CcSEcCtD
Liotrix—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000137	0.000855	CcSEcCtD
Liotrix—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.000854	CcSEcCtD
Liotrix—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000853	CcSEcCtD
Liotrix—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000136	0.000853	CcSEcCtD
Liotrix—Headache—Stavudine—acquired immunodeficiency syndrome	0.000136	0.00085	CcSEcCtD
Liotrix—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000136	0.00085	CcSEcCtD
Liotrix—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000849	CcSEcCtD
Liotrix—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000848	CcSEcCtD
Liotrix—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000848	CcSEcCtD
Liotrix—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000135	0.000846	CcSEcCtD
Liotrix—Rash—Abacavir—acquired immunodeficiency syndrome	0.000135	0.000843	CcSEcCtD
Liotrix—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000135	0.000842	CcSEcCtD
Liotrix—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000842	CcSEcCtD
Liotrix—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000842	CcSEcCtD
Liotrix—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000841	CcSEcCtD
Liotrix—Headache—Abacavir—acquired immunodeficiency syndrome	0.000134	0.000838	CcSEcCtD
Liotrix—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000837	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000836	CcSEcCtD
Liotrix—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000134	0.000835	CcSEcCtD
Liotrix—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.000835	CcSEcCtD
Liotrix—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000829	CcSEcCtD
Liotrix—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000828	CcSEcCtD
Liotrix—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000825	CcSEcCtD
Liotrix—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000823	CcSEcCtD
Liotrix—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000823	CcSEcCtD
Liotrix—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000819	CcSEcCtD
Liotrix—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000819	CcSEcCtD
Liotrix—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000818	CcSEcCtD
Liotrix—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000817	CcSEcCtD
Liotrix—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000814	CcSEcCtD
Liotrix—ABCB1—lung—acquired immunodeficiency syndrome	0.00013	0.00211	CbGeAlD
Liotrix—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000811	CcSEcCtD
Liotrix—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000129	0.000809	CcSEcCtD
Liotrix—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000808	CcSEcCtD
Liotrix—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.000807	CcSEcCtD
Liotrix—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000129	0.000806	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000804	CcSEcCtD
Liotrix—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000803	CcSEcCtD
Liotrix—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000798	CcSEcCtD
Liotrix—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000797	CcSEcCtD
Liotrix—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000127	0.000794	CcSEcCtD
Liotrix—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000793	CcSEcCtD
Liotrix—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000791	CcSEcCtD
Liotrix—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000788	CcSEcCtD
Liotrix—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000787	CcSEcCtD
Liotrix—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000787	CcSEcCtD
Liotrix—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000787	CcSEcCtD
Liotrix—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000784	CcSEcCtD
Liotrix—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000784	CcSEcCtD
Liotrix—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000784	CcSEcCtD
Liotrix—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000125	0.00078	CcSEcCtD
Liotrix—THRA—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000124	0.0145	CbGpPWpGaD
Liotrix—THRB—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000124	0.0145	CbGpPWpGaD
Liotrix—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000776	CcSEcCtD
Liotrix—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000767	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000767	CcSEcCtD
Liotrix—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000764	CcSEcCtD
Liotrix—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000762	CcSEcCtD
Liotrix—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000761	CcSEcCtD
Liotrix—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000756	CcSEcCtD
Liotrix—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000756	CcSEcCtD
Liotrix—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000755	CcSEcCtD
Liotrix—ABCB1—nervous system—acquired immunodeficiency syndrome	0.00012	0.00196	CbGeAlD
Liotrix—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000751	CcSEcCtD
Liotrix—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000751	CcSEcCtD
Liotrix—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.00075	CcSEcCtD
Liotrix—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.00075	CcSEcCtD
Liotrix—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000744	CcSEcCtD
Liotrix—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000744	CcSEcCtD
Liotrix—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000743	CcSEcCtD
Liotrix—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000739	CcSEcCtD
Liotrix—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000733	CcSEcCtD
Liotrix—THRB—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000117	0.0136	CbGpPWpGaD
Liotrix—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000732	CcSEcCtD
Liotrix—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000731	CcSEcCtD
Liotrix—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000729	CcSEcCtD
Liotrix—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000727	CcSEcCtD
Liotrix—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000726	CcSEcCtD
Liotrix—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000725	CcSEcCtD
Liotrix—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000725	CcSEcCtD
Liotrix—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000725	CcSEcCtD
Liotrix—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000116	0.00188	CbGeAlD
Liotrix—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000722	CcSEcCtD
Liotrix—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.00072	CcSEcCtD
Liotrix—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000712	CcSEcCtD
Liotrix—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000709	CcSEcCtD
Liotrix—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000702	CcSEcCtD
Liotrix—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000701	CcSEcCtD
Liotrix—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000701	CcSEcCtD
Liotrix—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000698	CcSEcCtD
Liotrix—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000698	CcSEcCtD
Liotrix—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000698	CcSEcCtD
Liotrix—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000694	CcSEcCtD
Liotrix—Rash—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000692	CcSEcCtD
Liotrix—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000691	CcSEcCtD
Liotrix—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000689	CcSEcCtD
Liotrix—Headache—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000687	CcSEcCtD
Liotrix—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000685	CcSEcCtD
Liotrix—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000679	CcSEcCtD
Liotrix—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000676	CcSEcCtD
Liotrix—SLCO1B3—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000108	0.0125	CbGpPWpGaD
Liotrix—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000669	CcSEcCtD
Liotrix—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000666	CcSEcCtD
Liotrix—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000666	CcSEcCtD
Liotrix—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000659	CcSEcCtD
Liotrix—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000658	CcSEcCtD
Liotrix—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000656	CcSEcCtD
Liotrix—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000654	CcSEcCtD
Liotrix—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000653	CcSEcCtD
Liotrix—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000652	CcSEcCtD
Liotrix—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.00065	CcSEcCtD
Liotrix—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000649	CcSEcCtD
Liotrix—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000649	CcSEcCtD
Liotrix—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000103	0.012	CbGpPWpGaD
Liotrix—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000633	CcSEcCtD
Liotrix—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000631	CcSEcCtD
Liotrix—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000627	CcSEcCtD
Liotrix—Rash—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000625	CcSEcCtD
Liotrix—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.99e-05	0.000625	CcSEcCtD
Liotrix—Pruritus—Saquinavir—acquired immunodeficiency syndrome	9.99e-05	0.000624	CcSEcCtD
Liotrix—Headache—Delavirdine—acquired immunodeficiency syndrome	9.94e-05	0.000621	CcSEcCtD
Liotrix—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.92e-05	0.00062	CcSEcCtD
Liotrix—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.85e-05	0.000616	CcSEcCtD
Liotrix—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.7e-05	0.000606	CcSEcCtD
Liotrix—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.66e-05	0.000604	CcSEcCtD
Liotrix—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.66e-05	0.000604	CcSEcCtD
Liotrix—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.53e-05	0.000596	CcSEcCtD
Liotrix—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.42e-05	0.000589	CcSEcCtD
Liotrix—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.34e-05	0.000584	CcSEcCtD
Liotrix—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.33e-05	0.000583	CcSEcCtD
Liotrix—Rash—Ritonavir—acquired immunodeficiency syndrome	9.25e-05	0.000578	CcSEcCtD
Liotrix—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.24e-05	0.000578	CcSEcCtD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.22e-05	0.0107	CbGpPWpGaD
Liotrix—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.22e-05	0.000576	CcSEcCtD
Liotrix—ABCB1—brain—acquired immunodeficiency syndrome	9.19e-05	0.0015	CbGeAlD
Liotrix—Headache—Ritonavir—acquired immunodeficiency syndrome	9.19e-05	0.000575	CcSEcCtD
Liotrix—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.98e-05	0.000561	CcSEcCtD
Liotrix—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.91e-05	0.000557	CcSEcCtD
Liotrix—Rash—Saquinavir—acquired immunodeficiency syndrome	8.9e-05	0.000557	CcSEcCtD
Liotrix—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.89e-05	0.000556	CcSEcCtD
Liotrix—ABCB1—lymph node—acquired immunodeficiency syndrome	8.88e-05	0.00144	CbGeAlD
Liotrix—Headache—Saquinavir—acquired immunodeficiency syndrome	8.85e-05	0.000553	CcSEcCtD
Liotrix—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.71e-05	0.000545	CcSEcCtD
Liotrix—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.56e-05	0.000535	CcSEcCtD
Liotrix—Rash—Lamivudine—acquired immunodeficiency syndrome	8.49e-05	0.000531	CcSEcCtD
Liotrix—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.48e-05	0.00053	CcSEcCtD
Liotrix—SLCO1A2—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	8.47e-05	0.00984	CbGpPWpGaD
Liotrix—Headache—Lamivudine—acquired immunodeficiency syndrome	8.44e-05	0.000528	CcSEcCtD
Liotrix—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.39e-05	0.000524	CcSEcCtD
Liotrix—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	8.11e-05	0.00943	CbGpPWpGaD
Liotrix—Nausea—Lamivudine—acquired immunodeficiency syndrome	8e-05	0.0005	CcSEcCtD
Liotrix—SLCO1B1—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	7.24e-05	0.00842	CbGpPWpGaD
Liotrix—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	6.93e-05	0.00806	CbGpPWpGaD
Liotrix—THRB—Gene Expression—CCNT1—acquired immunodeficiency syndrome	5.99e-05	0.00697	CbGpPWpGaD
Liotrix—THRA—Gene Expression—CCNT1—acquired immunodeficiency syndrome	5.99e-05	0.00697	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.77e-05	0.00671	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	4.88e-05	0.00567	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—TAT—acquired immunodeficiency syndrome	4.83e-05	0.00561	CbGpPWpGaD
Liotrix—SLCO4A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.67e-05	0.00543	CbGpPWpGaD
Liotrix—SLCO4C1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.67e-05	0.00543	CbGpPWpGaD
Liotrix—TTR—Disease—APOBEC3G—acquired immunodeficiency syndrome	4.66e-05	0.00542	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	4.58e-05	0.00533	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	4.57e-05	0.00531	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	4.57e-05	0.00531	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.54e-05	0.00527	CbGpPWpGaD
Liotrix—THRB—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	4.46e-05	0.00519	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.11e-05	0.00477	CbGpPWpGaD
Liotrix—TTR—Disease—CCNT1—acquired immunodeficiency syndrome	3.96e-05	0.00461	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	3.96e-05	0.0046	CbGpPWpGaD
Liotrix—SLCO1C1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.91e-05	0.00455	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.88e-05	0.00451	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	3.85e-05	0.00447	CbGpPWpGaD
Liotrix—THRB—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	3.6e-05	0.00419	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—TAT—acquired immunodeficiency syndrome	3.02e-05	0.00352	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	3e-05	0.00349	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	3e-05	0.00349	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	2.92e-05	0.00339	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	2.86e-05	0.00332	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	2.85e-05	0.00332	CbGpPWpGaD
Liotrix—SLC16A10—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.84e-05	0.0033	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.78e-05	0.00323	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.78e-05	0.00323	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AGPS—acquired immunodeficiency syndrome	2.57e-05	0.00299	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.51e-05	0.00292	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	2.38e-05	0.00276	CbGpPWpGaD
Liotrix—SLCO4A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.37e-05	0.00276	CbGpPWpGaD
Liotrix—SLCO4C1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.37e-05	0.00276	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	2.32e-05	0.0027	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.23e-05	0.00259	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.22e-05	0.00258	CbGpPWpGaD
Liotrix—SLCO1B3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.22e-05	0.00258	CbGpPWpGaD
Liotrix—TTR—Disease—CXCR4—acquired immunodeficiency syndrome	2.08e-05	0.00242	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	2.07e-05	0.0024	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—TAT—acquired immunodeficiency syndrome	2.03e-05	0.00236	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.02e-05	0.00235	CbGpPWpGaD
Liotrix—SLCO1C1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.99e-05	0.00231	CbGpPWpGaD
Liotrix—SLC22A8—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.96e-05	0.00228	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.89e-05	0.0022	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	1.85e-05	0.00215	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	1.85e-05	0.00215	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	1.76e-05	0.00205	CbGpPWpGaD
Liotrix—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.74e-05	0.00202	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.73e-05	0.00201	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.71e-05	0.00199	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	1.57e-05	0.00182	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.55e-05	0.0018	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	1.5e-05	0.00175	CbGpPWpGaD
Liotrix—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	1.49e-05	0.00173	CbGpPWpGaD
Liotrix—SLCO1B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.49e-05	0.00173	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	1.49e-05	0.00173	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.46e-05	0.0017	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.46e-05	0.0017	CbGpPWpGaD
Liotrix—SLC16A10—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.44e-05	0.00168	CbGpPWpGaD
Liotrix—TTR—Disease—CCR5—acquired immunodeficiency syndrome	1.43e-05	0.00166	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	1.21e-05	0.00141	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	1.2e-05	0.00139	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.18e-05	0.00138	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	1.17e-05	0.00136	CbGpPWpGaD
Liotrix—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	1.16e-05	0.00135	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.14e-05	0.00133	CbGpPWpGaD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.13e-05	0.00131	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.11e-05	0.00129	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.09e-05	0.00127	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.02e-05	0.00118	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.99e-06	0.00116	CbGpPWpGaD
Liotrix—SLC22A8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.96e-06	0.00116	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	9.93e-06	0.00115	CbGpPWpGaD
Liotrix—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	9.87e-06	0.00115	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	9.79e-06	0.00114	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	9.64e-06	0.00112	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.3e-06	0.00108	CbGpPWpGaD
Liotrix—TTR—Disease—CD4—acquired immunodeficiency syndrome	8.96e-06	0.00104	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.85e-06	0.00103	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	8.65e-06	0.00101	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—ALB—acquired immunodeficiency syndrome	8.42e-06	0.000979	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.96e-06	0.000925	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	7.85e-06	0.000913	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	7.66e-06	0.000891	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.56e-06	0.000879	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.77e-06	0.000671	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	5.63e-06	0.000655	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ALB—acquired immunodeficiency syndrome	5.27e-06	0.000613	CbGpPWpGaD
Liotrix—TTR—Disease—IL6—acquired immunodeficiency syndrome	4.85e-06	0.000563	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	4.57e-06	0.000531	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	4.14e-06	0.000482	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	4.05e-06	0.000471	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.79e-06	0.00044	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ALB—acquired immunodeficiency syndrome	3.54e-06	0.000412	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.39e-06	0.000395	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	2.04e-06	0.000237	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	1.77e-06	0.000206	CbGpPWpGaD
